• About us
• Contact

Advertisement

Organisation › Details

City Therapeutics Inc.

City Therapeutics is a biopharmaceutical company harnessing next-generation engineering of small interfering RNAs (siRNAs) to improve and expand the reach of RNAi-based medicines. The company is building a pipeline of innovative RNAi therapeutics to make a significant impact for patients across multiple therapeutic areas. Co-founded by pioneering executives and scientists in RNAi, City Therapeutics is based in Cambridge, MA, and has raised $135 million from leading life sciences investors. *

 

	Start	2024-10-08 start announced
	Industry	siRNA technology
	Industry 2	RNAi drug (RNAi therapeutic)
	Person	Orth, Andrew (Andy) (City Therapeutics 202501– CEO before Krystal Biotech + Alnylam + Biogen + Genzyme + Amgen)
	Person 2	Maraganore, John (ARCH Venture 202112– Venture Partner before founding CEO of Alnylam + Millennium + Biogen)
	Region	Cambridge, MA
	Country	United States (USA)
	Street	399 Binney Street
	City	02142 Cambridge, MA
		Address record changed: 2024-10-11
Basic data	Employees	n. a.
		* Document for »About Section«: City Therapeutics, Inc.. (10/8/24). "Press Release: City Therapeutics Launches with $135 Million Series A Financing to Lead the Future of RNAi-based Medicine". Cambridge, MA.
		Record changed: 2025-01-12

Advertisement

More documents for City Therapeutics Inc.

• [1] City Therapeutics, Inc.. (1/7/25). "Press Release: City Therapeutics Appoints Andy Orth as Chief Executive Officer". Cambridge, MA....
• [2] City Therapeutics, Inc.. (10/8/24). "Press Release: City Therapeutics Launches with $135 Million Series A Financing to Lead the Future of RNAi-based Medicine". Cambridge, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.